Kidney RISE: Randomized Integrated Supportive CarE Trial
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- NYU Langone Health
- Study ID
- NCT07741357
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Chronic Kidney Disease (Stages 4 and 5)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Kidney RISE — BEHAVIORALCore components include assessment of symptoms (IPOS-Renal), illness understanding, goals of care, advance care planning, spiritual needs, and screening for health-related social needs (HRSNs) using the validated Centers for Medicare and Medicaid Services (CMS) Accountable Health Communities (AHC) Survey. Plans will address symptom management with evidence-based algorithms, linkage to social or spiritual supports, and shared decision-making appropriate to CKD stage.
Study Details
The purpose of study is to investigate whether adding palliative care to usual chronic kidney disease (CKD) care improves symptoms and quality of life for people with CKD. The primary objectives are to 1) determine efficacy of Kidney Palliative Care (KPC) integrated with CKD care on symptom burden compared with usual CKD care, 2) identify clinical and demographic factors associated with differential responses to KPC, and 3) characterize participant and provider experiences with kidney care and factors influencing implementation.
Key Dates
- First listed
- Aug 3, 2026
- Start date
- May 31, 2027
- Status verified
- Jul 2026
- Primary completion
- Aug 31, 2030
- Completion
- Jan 31, 2031
Study Design
- Enrollment
- 280 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Integrated Kidney Palliative CareParticipants will receive integrated kidney palliative care (Kidney RISE) in addition to their usual CKD care. The integrated kidney palliative care consists of 4 kidney palliative care (KPC) intervention visits over 24 weeks by a KPC-trained palliative care provider in person or telehealth, each visit will last between 30-60 minutes.
- No Intervention: Usual Chronic Kidney Disease (CKD) CareParticipants in this arm will receive the usual CKD care.
Primary Outcome Measure
Change in Integrated Palliative Care Outcome Scale - Renal (IPOS-Renal) Patient Version scores [ Time Frame: Baseline, Week 12 ]
Central Contacts
- Jennifer Scherer, MD, MS, FASN212-263-0705
- Rachel Monahan
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Emory University | Atlanta | Georgia | 30322 | Dio Kavalieratos, MD (PRINCIPAL_INVESTIGATOR) |
| NYU Langone Health | New York | New York | 10016 | Jennifer Scherer, MD, MS, FASN (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Atlanta, GA
Related Studies
- Symptom Monitoring With Supported Feedback in Advanced Chronic Kidney DiseaseRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes MellitusRecruiting · Well Cell Global · Phoenix, Arizona
- Deceased Donor Kidney Storage at 10 Celsius Versus Conventional StorageRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee